These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 25879630)

  • 21. Comparative evaluation of microbial translocation products (LPS, sCD14, IgM Endocab) in HIV-1 infected Indian individuals.
    Negi N; Singh R; Sharma A; Das BK; Vajpayee M
    Microb Pathog; 2017 Oct; 111():331-337. PubMed ID: 28801271
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CD161+ MAIT cells are severely reduced in peripheral blood and lymph nodes of HIV-infected individuals independently of disease progression.
    Eberhard JM; Hartjen P; Kummer S; Schmidt RE; Bockhorn M; Lehmann C; Balagopal A; Hauber J; van Lunzen J; Schulze zur Wiesch J
    PLoS One; 2014; 9(11):e111323. PubMed ID: 25369333
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interleukin-15 (IL-15) Strongly Correlates with Increasing HIV-1 Viremia and Markers of Inflammation.
    Swaminathan S; Qiu J; Rupert AW; Hu Z; Higgins J; Dewar RL; Stevens R; Rehm CA; Metcalf JA; Sherman BT; Baseler MW; Lane HC; Imamichi T
    PLoS One; 2016; 11(11):e0167091. PubMed ID: 27880829
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dynamic observation of IL-33 and its receptors in HIV patients who received HAART.
    He B; Zheng L; Zhou H; He Y; Chen Z; Xiao S; Wang H; Ling Y; Zheng Y
    Cell Mol Biol (Noisy-le-grand); 2017 Mar; 63(3):73-77. PubMed ID: 28466817
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Altered clonogenic capability and stromal cell function characterize bone marrow of HIV-infected subjects with low CD4+ T cell counts despite viral suppression during HAART.
    Isgrò A; Leti W; De Santis W; Marziali M; Esposito A; Fimiani C; Luzi G; Pinti M; Cossarizza A; Aiuti F; Mezzaroma I
    Clin Infect Dis; 2008 Jun; 46(12):1902-10. PubMed ID: 18462177
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Insulin-like growth factor 1 inversely relates to monocyte/macrophage activation markers in HIV.
    Fourman LT; Czerwonka N; Shaikh SD; Stanley TL; Burdo TH; Williams KC; Fitch KV; Lo J; Grinspoon SK
    AIDS; 2018 Apr; 32(7):927-932. PubMed ID: 29424780
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antiretroviral therapy in HIV-1-infected individuals with CD4 count below 100 cells/mm3 results in differential recovery of monocyte activation.
    Patro SC; Azzoni L; Joseph J; Fair MG; Sierra-Madero JG; Rassool MS; Sanne I; Montaner LJ
    J Leukoc Biol; 2016 Jul; 100(1):223-31. PubMed ID: 26609048
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Decreases in plasma TNF-alpha level and IFN-gamma mRNA level in peripheral blood mononuclear cells (PBMC) and an increase in IL-2 mRNA level in PBMC are associated with effective highly active antiretroviral therapy in HIV-infected patients.
    Brazille P; Dereuddre-Bosquet N; Leport C; Clayette P; Boyer O; Vildé JL; Dormont D; Benveniste O
    Clin Exp Immunol; 2003 Feb; 131(2):304-11. PubMed ID: 12562393
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNA-29 family expression and its relation to antiviral immune response and viro-immunological markers in HIV-1-infected patients.
    Monteleone K; Selvaggi C; Cacciotti G; Falasca F; Mezzaroma I; D'Ettorre G; Turriziani O; Vullo V; Antonelli G; Scagnolari C
    BMC Infect Dis; 2015 Feb; 15():51. PubMed ID: 25808800
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of Interleukin-28B polymorphism on Interleukin-28 expression and immunological recovery amongst HIV-1-infected individuals following antiretroviral therapy.
    Srinidhi BV; Fletcher GJ; Sachidanantham J; Rupali P; Ramalingam VV; Demosthenes JP; Abraham OC; Pulimood SA; Rebekah G; Kannangai R
    Indian J Med Microbiol; 2017; 35(4):580-584. PubMed ID: 29405153
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Monocyte activation, HIV, and cognitive performance in East Africa.
    Muñoz-Nevárez LA; Imp BM; Eller MA; Kiweewa F; Maswai J; Polyak C; Olwenyi OA; Allen IE; Rono E; Milanini B; Kibuuka H; Ake JA; Eller LA; Valcour VG
    J Neurovirol; 2020 Feb; 26(1):52-59. PubMed ID: 31468471
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased soluble CD14 serum levels and altered CD14 expression of peripheral blood monocytes in HIV-infected patients.
    Nockher WA; Bergmann L; Scherberich JE
    Clin Exp Immunol; 1994 Dec; 98(3):369-74. PubMed ID: 7527738
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Soluble CD163, a novel marker of activated macrophages, is elevated and associated with noncalcified coronary plaque in HIV-infected patients.
    Burdo TH; Lo J; Abbara S; Wei J; DeLelys ME; Preffer F; Rosenberg ES; Williams KC; Grinspoon S
    J Infect Dis; 2011 Oct; 204(8):1227-36. PubMed ID: 21917896
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HIV and cardiovascular diseases risk: exploring the interplay between T-cell activation, coagulation, monocyte subsets, and lipid subclass alterations.
    Teer E; Joseph DE; Driescher N; Nell TA; Dominick L; Midgley N; Deshpande G; Page MJ; Pretorius E; Woudberg NJ; Lecour S; Glashoff RH; Essop MF
    Am J Physiol Heart Circ Physiol; 2019 May; 316(5):H1146-H1157. PubMed ID: 30768357
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic polymorphisms in the CD14 gene are associated with monocyte activation and carotid intima-media thickness in HIV-infected patients on antiretroviral therapy.
    Yong YK; Shankar EM; Westhorpe CLV; Maisa A; Spelman T; Kamarulzaman A; Crowe SM; Lewin SR
    Medicine (Baltimore); 2016 Aug; 95(31):e4477. PubMed ID: 27495090
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Persisting inflammation and chronic immune activation but intact cognitive function in HIV-infected patients after long-term treatment with combination antiretroviral therapy.
    Pedersen KK; Pedersen M; Gaardbo JC; Ronit A; Hartling HJ; Bruunsgaard H; Gerstoft J; Ullum H; Nielsen SD
    J Acquir Immune Defic Syndr; 2013 Jul; 63(3):272-9. PubMed ID: 23392469
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of monotherapy on HIV-1 reservoir, immune activation, and co-infection with Epstein-Barr virus.
    Petrara MR; Cattelan AM; Sasset L; Freguja R; Carmona F; Sanavia S; Zanchetta M; Del Bianco P; De Rossi A
    PLoS One; 2017; 12(9):e0185128. PubMed ID: 28926641
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Soluble CD163 and soluble CD14 plasma levels but not cellular HIV-DNA decrease during successful interferon-free anti-HCV therapy in HIV-1-HCV co-infected patients on effective combined anti-HIV treatment.
    Parisi SG; Andreis S; Mengoli C; Menegotto N; Cavinato S; Scaggiante R; Andreoni M; Palù G; Basso M; Cattelan AM
    Med Microbiol Immunol; 2018 Aug; 207(3-4):183-194. PubMed ID: 29523966
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of type 1 and type 2 cytokines in HIV type 1-infected individuals: impact of highly active antiretroviral therapy.
    Imami N; Antonopoulos C; Hardy GA; Gazzard B; Gotch FM
    AIDS Res Hum Retroviruses; 1999 Nov; 15(17):1499-508. PubMed ID: 10580400
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Asymptomatic HIV People Present Different Profiles of sCD14, sRAGE, DNA Damage, and Vitamins, according to the Use of cART and CD4
    Tasca KI; Correa CR; Caleffi JT; Mendes MB; Gatto M; Manfio VM; de Camargo CC; Tavares FC; Biasin M; de Souza LDR
    J Immunol Res; 2018; 2018():7531718. PubMed ID: 29992171
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.